Beranda › Mieloma Multipel › California › Santa Monica
Uji klinis Mieloma Multipel di Santa Monica, CA
8 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Santa Monica (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
Menerima pesertaFase 2
- Beverly Hills Cancer Center (BHCC), Beverly Hills · 6 mi jauhnya
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Menerima pesertaFase 3
- Research Site, Santa Monica
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
- Beverly Hills Cancer Center Clinical Research Advisors LLC, Beverly Hills · 6 mi jauhnya
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Menerima pesertaFase 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi jauhnya
- Clinical Research Advisors (Encino Satellite Location), Encino · 10 mi jauhnya
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Menerima pesertaFase 3
- Research Site, Santa Monica
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Menerima pesertaFase 1
- UCLA Health, Jonsson Comprehensive Cancer Center, Santa Monica
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- Beverly Hills Cancer Center /ID# 266921, Beverly Hills · 6 mi jauhnya
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Menerima pesertaFase 3
- GSK Investigational Site, Beverly Hills · 6 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA42 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Baldwin Park, CA23 studi
- Edison, NJ22 studi
Studi lain di Santa Monica
- Kanker Paru Non-Sel Kecil45 studi
- Kanker Payudara28 studi
- Kanker Kolorektal23 studi
- Kanker (semua jenis)22 studi
- Kanker Metastatik19 studi
- Kanker Paru15 studi
- Kanker Ovarium15 studi
- Kanker Prostat15 studi
- Karsinoma Sel Skuamosa Kepala dan Leher13 studi
- Gagal Jantung11 studi
- Kanker Endometrium10 studi
- Kanker Lambung9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.